INOZYME PHARMA, INC. Stock Split Ratio
INOZYME PHARMA, INC. had Stock Split Ratio of 13.38% as of 2020-07-17, per its 10-K filed 2024-03-12.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-03-12
- 2020-07-17: Stockholders' Equity Note, Stock Split, Conversion Ratio 13.38%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2020-07-17 | 13.38% 10-K · filed 2024-03-12 |